PLATELET RICH BLOOD PLASMA

Brand Owner (click to sort) Address Description
INS NEUX TECHNOLOGIES, INC. 801 Northpoint Parkway, Suite 37 West Palm Beach FL 33407 Platelet rich blood plasma and stem cells for medical purposes, for use in the diagnosis, treatment, and prevention of musculoskeletal disorders, arthritis, pain and injuries;
MR-PRP Mishra, Allan 340 August Circle Menlo Park CA 94025 Platelet rich blood plasma; Pharmaceutical preparations for treatment and prevention of tissue injuries, disorders, and diseases, and for promotion of cell and tissue regeneration; Medicaments for promoting recovery from tissue injuries, disorders, and diseases, and to help assist with the regeneration of cells and tissue;
VITAKINE Mishra, Allan 340 August Circle Menlo Park CA 94025 Platelet rich blood plasma; pharmaceutical preparations for treatment and prevention of tendon and muscle injuries and disorders, skin disorders and diseases, cardiac disorders and diseases, brain disorders and diseases, and sports related injuries, and for promotion of knee cartilage regeneration; medicaments for promoting recovery from tendon and muscle injuries and disorders, skin disorders, cardiac disorders and diseases, brain disorders and diseases and sports related injuries, and to help assist with the regeneration of ligament and tendon fibers;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. An object is to provide a blood component collection system capable of collecting a desired blood component of high quality. A blood component collection system 1 comprises a centrifugal separator 20 centrifuging blood into a plurality of components, first line 21 for feeding the blood to the centrifugal separator 20, a second line 22 for releasing the blood component from the centrifugal separator 20, a temporary reservoir bag 26' for temporarily reserving the platelet concentrate, a leukoreduction filter 261 for separating and reducing leukocyte from the platelet concentrate, and a platelet collection bag 26 for reserving the platelet concentrate having passed through the leukoreduction filter 261. The blood component collection system 1 is constructed to feed the platelet concentrate in the temporary reservoir bag 26' to the platelet collection bag 26 through the leukoreduction filter 261, and then, feed plasma and collect the platelet remaining in the leukoreduction filter 261 (platelet concentrate from which leukocyte have been reduced) together with the plasma into the platelet collection bag 26.